Literature DB >> 19300976

[Special features of pharmacotherapy in older hypertensive subjects].

R Kreutz1.   

Abstract

The prevalence of arterial hypertension in Germany is 60-80% in individuals between 65 and 74 years of age. In older people there is also a positive correlation between blood pressure level and rise in mortality due to myocardial infarction and stroke. Antihypertensive therapy can considerably improve the prognosis of older hypertensive individuals. Treatment is of enormous importance in these patients, particularly for prevention of strokes, which will continue to increase in the future as a result of demographic trends. Older patients have an elevated risk of developing undesirable drug reactions while under therapy such as a drop in blood pressure in an erect/standing position. Taking into account individual risk factors for unwanted events and avoidance of drug interactions during polypharmacotherapy are important aspects in differential therapy with antihypertensive agents in the elderly.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19300976     DOI: 10.1007/s00108-008-2293-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  54 in total

Review 1.  Stroke is more common than myocardial infarction in hypertension: analysis based on 11 major randomized intervention trials.

Authors:  S E Kjeldsen; S Julius; T Hedner; L Hansson
Journal:  Blood Press       Date:  2001       Impact factor: 2.835

Review 2.  An updated clinical primer on large artery mechanics: implications of pulse waveform analysis and arterial tonometry.

Authors:  Michael F O'Rourke; Audrey Adji
Journal:  Curr Opin Cardiol       Date:  2005-07       Impact factor: 2.161

Review 3.  Cardiovascular protection using beta-blockers: a critical review of the evidence.

Authors:  Sripal Bangalore; Franz H Messerli; John B Kostis; Carl J Pepine
Journal:  J Am Coll Cardiol       Date:  2007-07-30       Impact factor: 24.094

Review 4.  Clinical practice. Isolated systolic hypertension in the elderly.

Authors:  Aram V Chobanian
Journal:  N Engl J Med       Date:  2007-08-23       Impact factor: 91.245

5.  Antihypertensive treatment and dementia prevention.

Authors:  Ingmar Skoog
Journal:  Lancet Neurol       Date:  2008-07-07       Impact factor: 44.182

6.  Randomised double-blind comparison of placebo and active treatment for older patients with isolated systolic hypertension. The Systolic Hypertension in Europe (Syst-Eur) Trial Investigators.

Authors:  J A Staessen; R Fagard; L Thijs; H Celis; G G Arabidze; W H Birkenhäger; C J Bulpitt; P W de Leeuw; C T Dollery; A E Fletcher; F Forette; G Leonetti; C Nachev; E T O'Brien; J Rosenfeld; J L Rodicio; J Tuomilehto; A Zanchetti
Journal:  Lancet       Date:  1997-09-13       Impact factor: 79.321

7.  Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension. Final results of the Systolic Hypertension in the Elderly Program (SHEP). SHEP Cooperative Research Group.

Authors: 
Journal:  JAMA       Date:  1991-06-26       Impact factor: 56.272

8.  The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial.

Authors:  Hans Lithell; Lennart Hansson; Ingmar Skoog; Dag Elmfeldt; Albert Hofman; Bertil Olofsson; Peter Trenkwalder; Alberto Zanchetti
Journal:  J Hypertens       Date:  2003-05       Impact factor: 4.844

9.  Incident dementia and blood pressure lowering in the Hypertension in the Very Elderly Trial cognitive function assessment (HYVET-COG): a double-blind, placebo controlled trial.

Authors:  Ruth Peters; Nigel Beckett; Francoise Forette; Jaakko Tuomilehto; Robert Clarke; Craig Ritchie; Adam Waldman; Ivan Walton; Ruth Poulter; Shuping Ma; Marius Comsa; Lisa Burch; Astrid Fletcher; Christopher Bulpitt
Journal:  Lancet Neurol       Date:  2008-07-07       Impact factor: 44.182

Review 10.  Kidney disease as a risk factor for development of cardiovascular disease: a statement from the American Heart Association Councils on Kidney in Cardiovascular Disease, High Blood Pressure Research, Clinical Cardiology, and Epidemiology and Prevention.

Authors:  Mark J Sarnak; Andrew S Levey; Anton C Schoolwerth; Josef Coresh; Bruce Culleton; L Lee Hamm; Peter A McCullough; Bertram L Kasiske; Ellie Kelepouris; Michael J Klag; Patrick Parfrey; Marc Pfeffer; Leopoldo Raij; David J Spinosa; Peter W Wilson
Journal:  Circulation       Date:  2003-10-28       Impact factor: 29.690

View more
  1 in total

1.  Managing hypertension among nursing-home residents and community-dwelling elderly in Germany: a comparative pharmacoepidemiological study.

Authors:  Sophie Lochner; Wilhelm Kirch; Christoph Schindler
Journal:  Eur J Clin Pharmacol       Date:  2011-12-30       Impact factor: 2.953

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.